Rimon

Entries tagged “Dr. Michael Ye”

Energem Corp. Announces Closing of Initial Public Offering and Exercise of Full Over-Allotment Option

news Energem Corp. Announces Closing of Initial Public Offering and Exercise of Full Over-Allotment Option Debbie A. Klis · November 19, 2021

Kuala Lumpur, Malaysia / November 18, 2021 / Energem Corp. (the “Company”) announced today the closing of its initial public offering of 10,000,000 units at $10.00 per unit. Each unit consists of one Class A ordinary share and one redeemable warrant. Each warrant entitles the holder to purchase one Class A ordinary share at a…

Continue Reading…

Global Law Firm Rimon PC Adds Three Intellectual Property Partners to Washington, D.C. Office

news November 9, 2021

Washington, D.C. – Increasing its team of pharmaceutical and biotech IP attorneys, Rimon is pleased to welcome  Dr. Ping Wang, Dr. Michael Ye, and Dr. John Murray as Intellectual Property and Patent Prosecution partners in the firm’s Washington D.C. office. The group joins the firm from Morris Manning and Martin, LLP. “Pharma and biotech are…

Continue Reading…